Table 2.
Clinical samples and external quality control samples (provided by INSTAND e.V., Düsseldorf, Germany) were tested for potential cross-reactivity with the E-Gene-LDT.
| Positive clinical samples | Number | Result |
|---|---|---|
| hCoV 229E | 2 | Negative |
| hCoV HKU1 | 2 | Negative |
| Influenza A | 3 | Negative |
| Influenza A H1N1 | 2 | Negative |
| Influenza B | 2 | Negative |
| RSV | 3 | Negative |
| Rhino-/Enterovirus | 2 | Negative |
| Human Metapneumovirus | 2 | Negative |
| Parainfluenzavirus 3 | 1 | Negative |
| Adenovirus | 1 | Negative |
| Boca-virus | 2 | Negative |
| Mycoplasma pneumoniae | 1 | Negative |
| Chlamydophila pneumoniae | 1 | Negative |
| Pneumocystis jirovecii | 1 | Negative |
| External quality assessment panels (INSTAND) | ||
| MERS Coronavirus | 2 | Negative |
| hCoV NL63 | 1 | Negative |
| hCoV 229E | 1 | Negative |
| hCoV OC43 | 1 | Negative |
| Parainfluenzavirus 2 | 1 | Negative |
| Parainfluenzavirus 3 | 1 | Negative |
| Total number tested: | 32 | |